LIFENET HEALTH

LifeNet Health is a global leader in regenerative medicine and organ procurement, specializing in the manufacture and distribution of allograft bio-implants for surgical applications. The company produces a comprehensive portfolio of decellularized tissue grafts serving multiple surgical specialties: cardiac, vascular, sports medicine, general orthopedics, trauma and extremities, craniomaxillofacial, spine, dental, and wound management and surgical reconstruction. Flagship products include Nexeon® Advanced Vascular Allograft, a decellularized, sterile, room-temperature vascular allograft, and Matrion® products for diabetic foot ulcer treatment, which recently won a Best Randomized Controlled Trial Award. The organization operates as an organ procurement organization (OPO) and has facilitated over 13,000 organ transplants and 13 million allograft implants. LifeNet Health maintains ISO 9001:2015 certification for its Assay Services Laboratory in Kalamazoo, Michigan, and supports both clinical surgery and biomedical research through its LifeNet Life Sciences division. The company serves healthcare providers, surgical institutions, and research organizations globally, with a focus on innovative tissue-based solutions that improve patient outcomes across multiple surgical disciplines.